Yuyu Pharma, Inc.
Símbolo: 000220.KS
KSC
4650
KRWPrecio de mercado actual
-11.1660
Ratio PER
0.0861
Ratio PEG
75.25B
Capitalización MRK
- 0.02%
Rendimiento DIV
Yuyu Pharma, Inc. (000220-KS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 103060.54 | 30604.9 | 30777.6 | 50263.5 | |||||||||||||||||
balance-sheet.row.short-term-investments | 6609.94 | 1749.3 | 4939.1 | -2909.2 | |||||||||||||||||
balance-sheet.row.net-receivables | 105320.57 | 24454.5 | 25308.8 | 22905.2 | |||||||||||||||||
balance-sheet.row.inventory | 181499.19 | 44152.2 | 39832 | 25225.3 | |||||||||||||||||
balance-sheet.row.other-current-assets | 3582.18 | 2384.9 | 439.3 | 494 | |||||||||||||||||
balance-sheet.row.total-current-assets | 393462.47 | 101596.5 | 96357.7 | 98887.9 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 326050.89 | 81402.7 | 81371.3 | 80341.4 | |||||||||||||||||
balance-sheet.row.goodwill | 864.67 | 503.2 | 50.8 | 50.8 | |||||||||||||||||
balance-sheet.row.intangible-assets | 15505.95 | 3764.5 | 3666.5 | 4087.1 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 16370.62 | 4267.7 | 3717.3 | 4137.9 | |||||||||||||||||
balance-sheet.row.long-term-investments | 28528.97 | 10815.2 | 1004.7 | 8945 | |||||||||||||||||
balance-sheet.row.tax-assets | 16931.16 | 3764.5 | -1004.7 | -8945 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 10614.46 | -3633.1 | 13758.7 | 9618.1 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 398496.09 | 96617 | 98847.3 | 94097.4 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 791958.56 | 198213.5 | 195205.1 | 192985.3 | |||||||||||||||||
balance-sheet.row.account-payables | 50041.57 | 10951.8 | 15840.5 | 8982.3 | |||||||||||||||||
balance-sheet.row.short-term-debt | 111167.67 | 25386.2 | 37425 | 10427.3 | |||||||||||||||||
balance-sheet.row.tax-payables | 3627.81 | 574.8 | 515.4 | 1004.5 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 57951.05 | 13640 | 1851.4 | 28739.1 | |||||||||||||||||
Deferred Revenue Non Current | 5198.12 | 380.9 | 0 | 2649.5 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 17759.78 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 24238.25 | 12247.1 | 10366.1 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 92996.28 | 27882.7 | 7515.5 | 34285.5 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 2486.97 | 380.9 | 793.8 | 697.8 | |||||||||||||||||
balance-sheet.row.total-liab | 306986.73 | 77857.9 | 71831 | 64300.2 | |||||||||||||||||
balance-sheet.row.preferred-stock | 10369.96 | 2592.5 | 2592.5 | 2592.5 | |||||||||||||||||
balance-sheet.row.common-stock | 70436.76 | 17609.2 | 17609.2 | 17609.2 | |||||||||||||||||
balance-sheet.row.retained-earnings | 92358.42 | 13946.5 | 31395.9 | 36540.4 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 41548.45 | 25885.4 | 23796 | 24242.5 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 240307.31 | 52154.1 | 41422.7 | 43296.7 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 455020.89 | 112187.6 | 116816.2 | 124281.2 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 784299.41 | 198213.5 | 195205.1 | 192985.3 | |||||||||||||||||
balance-sheet.row.minority-interest | 29950.93 | 8168 | 6557.8 | 4403.9 | |||||||||||||||||
balance-sheet.row.total-equity | 484971.83 | 120355.7 | 123374 | 128685.1 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 784299.41 | - | - | - | |||||||||||||||||
Total Investments | 33389.61 | 10815.2 | 5943.8 | 6035.9 | |||||||||||||||||
balance-sheet.row.total-debt | 169499.64 | 39407.2 | 39276.4 | 39166.5 | |||||||||||||||||
balance-sheet.row.net-debt | 71299.75 | 8802.3 | 13437.8 | -11097 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -6079.58 | -7180.9 | -4425.4 | -920.3 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 5607.33 | 5607.3 | 5027.4 | 4503 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 2698.8 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | -42.4 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -6772.53 | -6772.5 | -13150.7 | -3703.6 | |||||||||||||||||
cash-flows.row.account-receivables | 918.94 | 918.9 | -1760.7 | -3016.3 | |||||||||||||||||
cash-flows.row.inventory | -3424.07 | -3424.1 | -15133.5 | -1366.8 | |||||||||||||||||
cash-flows.row.account-payables | -5527.35 | -5527.3 | 7090.7 | 3715.8 | |||||||||||||||||
cash-flows.row.other-working-capital | 1259.95 | 1260 | -3347.2 | -3036.3 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 7724.58 | 9185.2 | 6319.7 | 1973.2 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 479.81 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -5106.22 | -5106.2 | -5567.7 | -6750.9 | |||||||||||||||||
cash-flows.row.acquisitions-net | -1180.28 | -770.9 | 4.6 | 1029 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -606.01 | -606 | -3833.6 | -822.3 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 3035.44 | 3047.3 | 506 | 701.6 | |||||||||||||||||
cash-flows.row.other-investing-activites | 831.04 | -346.4 | 346.9 | -47 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -3026.03 | -3782.2 | -8543.8 | -5889.6 | |||||||||||||||||
cash-flows.row.debt-repayment | -28407 | -10449.7 | -6253.3 | -906.8 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -1785.2 | 0 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -2001.7 | -2033.7 | -1851.2 | |||||||||||||||||
cash-flows.row.other-financing-activites | 37721.24 | 20160.8 | 989.1 | 34071 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 7312.51 | 7709.4 | -9083.2 | 31313 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.01 | 0 | -568.9 | 8.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 4766.3 | 4766.3 | -24424.9 | 29940.6 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 98199.89 | 30604.9 | 25838.6 | 50263.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 93433.59 | 25838.6 | 50263.5 | 20322.8 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 479.81 | 839.1 | -6229 | 4508.7 | |||||||||||||||||
cash-flows.row.capital-expenditure | -5106.22 | -5106.2 | -5567.7 | -6750.9 | |||||||||||||||||
cash-flows.row.free-cash-flow | -4626.41 | -4267.1 | -11796.7 | -2242.2 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 137209.59 | 137209.6 | 138881.1 | 115655.5 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 88978.45 | 90704.5 | 85567.9 | 70320.1 | |||||||||||||||||
income-statement-row.row.gross-profit | 48231.14 | 46505.1 | 53313.1 | 45335.4 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 7187.64 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 26369 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 11707.31 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -28303.31 | -219.2 | 25291.4 | 23750.8 | |||||||||||||||||
income-statement-row.row.operating-expenses | 22970.6 | 47254.1 | 53905.3 | 44135.2 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 112820.26 | 137958.5 | 139473.2 | 114455.3 | |||||||||||||||||
income-statement-row.row.interest-income | 896.74 | 896.7 | 561.7 | 201 | |||||||||||||||||
income-statement-row.row.interest-expense | 3677.09 | 2553.8 | 2580.7 | 2175.4 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 11707.31 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -5386.11 | -4199.5 | -4502.1 | -3036.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -28303.31 | -219.2 | 25291.4 | 23750.8 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -5386.11 | -4199.5 | -4502.1 | -3036.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 3677.09 | 2553.8 | 2580.7 | 2175.4 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 27466.73 | 5607.3 | 5027.4 | 4503 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 26890.08 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | -169.19 | -748.9 | 691.7 | 2653.5 | |||||||||||||||||
income-statement-row.row.income-before-tax | -5555.29 | -4948.5 | -3810.4 | -383.2 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 98.44 | 98.4 | 615 | 537.1 | |||||||||||||||||
income-statement-row.row.net-income | -6818.85 | -7180.9 | -4425.4 | -920.3 |
Preguntas frecuentes
Cuánto es Yuyu Pharma, Inc. (000220.KS) activos totales?
Yuyu Pharma, Inc. (000220.KS) los activos totales son 198213526767.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 68699340722.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.352.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es -285.886.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es -0.050.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son -0.001.
¿Qué es Yuyu Pharma, Inc. (000220.KS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es -7180899668.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 39407153086.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 47254050269.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 30604882236.000.